Total Payments
$44,563
2024 Payments
$4,226
Companies
29
Transactions
277
Medicare Patients
1,165
Medicare Billing
$186,303
Payment Breakdown by Category
Other$30,400 (68.2%)
Food & Beverage$6,196 (13.9%)
Travel$3,207 (7.2%)
Consulting$2,900 (6.5%)
Research$1,500 (3.4%)
Education$360.09 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $30,400 | 19 | 68.2% |
| Food and Beverage | $6,196 | 233 | 13.9% |
| Travel and Lodging | $3,207 | 14 | 7.2% |
| Consulting Fee | $2,900 | 2 | 6.5% |
| Unspecified | $1,500 | 1 | 3.4% |
| Education | $360.09 | 8 | 0.8% |
Payments by Type
General
$43,063
276 transactions
Research
$1,500
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CALLIDITAS THERAPEUTICS US INC. | $36,601 | 44 | $0 (2024) |
| Lutonix, Inc. | $1,500 | 1 | $0 (2017) |
| W. L. Gore & Associates, Inc. | $1,124 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $937.81 | 52 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $879.67 | 35 | $0 (2024) |
| Amgen Inc. | $486.30 | 22 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $392.89 | 18 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $286.94 | 16 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $260.13 | 3 | $0 (2018) |
| Aurinia Pharma U.S., Inc. | $218.61 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,226 | 43 | CALLIDITAS THERAPEUTICS US INC. ($3,397) |
| 2023 | $29,851 | 62 | Calliditas Therapeutics US Inc. ($29,086) |
| 2022 | $4,980 | 35 | CALLIDITAS THERAPEUTICS US INC. ($4,119) |
| 2021 | $619.32 | 36 | AstraZeneca Pharmaceuticals LP ($351.03) |
| 2020 | $624.40 | 24 | Otsuka America Pharmaceutical, Inc. ($316.85) |
| 2019 | $774.42 | 28 | Otsuka America Pharmaceutical, Inc. ($223.70) |
| 2018 | $577.81 | 20 | Bard Peripheral Vascular, Inc. ($143.90) |
| 2017 | $2,911 | 29 | Lutonix, Inc. ($1,500) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 12/06/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Rare Disease | ||||||
| 11/21/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: NEPHROLOGY | ||||||
| 11/01/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $31.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $10.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $10.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Nephrology | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: DIABETES | ||||||
| 09/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Rare Disease | ||||||
| 08/23/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $23.78 | General |
| 08/15/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/21/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Nephrology | ||||||
| 06/05/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $800.00 | General |
| Category: Nephrology | ||||||
| 05/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Rare Disease | ||||||
| 05/16/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: NEPHROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LTX AV | Lutonix, Inc. | $1,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 57 | 61 | $10,725 | $4,060 |
| 2022 | 5 | 177 | 213 | $82,117 | $29,563 |
| 2021 | 8 | 278 | 486 | $139,417 | $48,685 |
| 2020 | 12 | 653 | 993 | $316,337 | $103,995 |
Total Patients
1,165
Total Services
1,753
Medicare Billing
$186,303
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 30 | $5,850 | $2,055 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $2,475 | $1,138 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 20 | $2,400 | $867.06 | 36.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 32 | 43 | $33,196 | $12,001 | 36.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 26 | 33 | $21,384 | $7,638 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 57 | $11,115 | $4,190 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 57 | 62 | $7,440 | $2,941 | 39.5% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 12 | 18 | $8,982 | $2,793 | 31.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 14 | 62 | $47,864 | $17,607 | 36.8% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 18 | 71 | $35,429 | $11,095 | 31.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 39 | 42 | $12,054 | $4,369 | 36.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 40 | 75 | $10,125 | $4,181 | 41.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 29 | 60 | $12,720 | $3,414 | 26.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 57 | 64 | $7,680 | $3,247 | 42.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 31 | 33 | $6,435 | $2,488 | 38.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 50 | 79 | $7,110 | $2,285 | 32.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 90 | 126 | $97,272 | $28,936 | 29.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 88 | 98 | $63,504 | $18,889 | 29.7% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 36 | 99 | $49,401 | $14,253 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 99 | 208 | $28,080 | $11,895 | 42.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 67 | 143 | $25,025 | $11,659 | 46.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 82 | 102 | $19,890 | $5,983 | 30.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 31 | 33 | $9,471 | $3,566 | 37.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 49 | 54 | $8,100 | $2,999 | 37.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 41 | 45 | $5,400 | $1,802 | 33.4% |
About Dr. Kenneth Abreo, MBBS
Dr. Kenneth Abreo, MBBS is a Internal Medicine healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750303145.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Abreo, MBBS has received a total of $44,563 in payments from pharmaceutical and medical device companies, with $4,226 received in 2024. These payments were reported across 277 transactions from 29 companies. The most common payment nature is "Honoraria" ($30,400).
As a Medicare-enrolled provider, Abreo has provided services to 1,165 Medicare beneficiaries, totaling 1,753 services with total Medicare billing of $186,303. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Shreveport, LA
- Active Since 07/24/2006
- Last Updated 03/11/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750303145
Products in Payments
- TARPEYO (Drug) $36,601
- BPV-Lutonix (Device) $1,518
- LOKELMA (Drug) $925.30
- JYNARQUE (Drug) $837.89
- ACTHAR (Biological) $587.54
- VIABAHN Endoprosthesis with Heparin Bioactive Surface (Device) $493.44
- Velphoro (Drug) $275.37
- Veltassa (Drug) $262.19
- VIABAHN VBX Balloon Expandable Endoprosthesis (Device) $234.11
- Parsabiv (Biological) $218.24
- ACUSEAL Vascular Graft (Device) $217.39
- INJECTAFER (Drug) $192.28
- BENLYSTA (Biological) $188.04
- Vena Cava Filter (Device) $179.03
- NXSTAGE SYSTEM ONE (Device) $163.90
- LUTONIX (Device) $143.90
- Parsabiv (Drug) $133.22
- ULTOMIRIS (Biological) $131.85
- KRYSTEXXA (Biological) $124.99
- Kerendia (Drug) $100.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shreveport
Dr. Sreedhara Alla, M.d, M.D
Internal Medicine — Payments: $637,707
Internal Medicine $637,707
Steven Bailey, Md, MD
Internal Medicine — Payments: $301,538
Internal Medicine $301,538
Prakash Peddi, Md, MD
Internal Medicine — Payments: $277,646
Internal Medicine $277,646
Dr. Maxwell Mcdonald, Md, MD
Internal Medicine — Payments: $192,842
Internal Medicine $192,842
Laurie Grier, M.d, M.D
Internal Medicine — Payments: $69,555
Internal Medicine $69,555
Dr. Rajan Khanna, Md, MD
Internal Medicine — Payments: $66,411
Internal Medicine $66,411